Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future

Area of Science:

• Genetics and Bioethics
• Human Genome Editing Research
• Public Health Policy

Background:

• Historical context of human genetic engineering debates in the 1980s.
• The role of the National Institutes of Health (NIH) Recombinant DNA Advisory Committee (RAC) in reviewing early proposals for human DNA introduction.
• Development of guidelines for DNA transfer into patients and commentary on germline alteration possibilities by the RAC in 1984-1985.

Observation:

• Tracking textual evolution in the RAC's stance on germline genetic intervention.
• The abolition of the NIH RAC in 2019.
• Advancements in genome editing technologies, such as CRISPR, increasing feasibility of somatic and germline alterations.

Findings:

• The RAC's historical engagement with germline intervention discussions.
• The emergence of new genome editing capabilities necessitates updated oversight.
• Current oversight structures are insufficient for novel HHGE proposals.

Implications:

• Need for a robust public oversight framework for heritable human genome editing (HHGE).
• Proposal for a dual review system: technical review by a regulatory agency and public evaluation by a Bioethics Advisory Commission.
• Ensuring ethical considerations and public trust in the advancement of human genome editing technologies.